Cargando…

Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland

Visit of Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland

Detalles Bibliográficos
Autor principal: Ordan, Julien Marius
Publicado: 2018
Materias:
Acceso en línea:http://cds.cern.ch/record/2302055
_version_ 1780957236606009344
author Ordan, Julien Marius
author_facet Ordan, Julien Marius
author_sort Ordan, Julien Marius
collection CERN
description Visit of Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland
id cern-2302055
institution Organización Europea para la Investigación Nuclear
publishDate 2018
record_format invenio
spelling cern-23020552019-09-30T06:29:59Zhttp://cds.cern.ch/record/2302055Ordan, Julien MariusDr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern IrelandPhotolabVisit of Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern IrelandCERN-PHOTO-201801-022oai:cds.cern.ch:23020552018
spellingShingle Photolab
Ordan, Julien Marius
Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland
title Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland
title_full Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland
title_fullStr Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland
title_full_unstemmed Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland
title_short Dr Patrick Vallance President, R&D GlaxoSmithKline United Kingdom of Great Britain and Northern Ireland
title_sort dr patrick vallance president, r&d glaxosmithkline united kingdom of great britain and northern ireland
topic Photolab
url http://cds.cern.ch/record/2302055
work_keys_str_mv AT ordanjulienmarius drpatrickvallancepresidentrdglaxosmithklineunitedkingdomofgreatbritainandnorthernireland